Stopping azithromycin mass drug administration for trachoma: A systematic review.

The World Health Organization (WHO) recommends continuing azithromycin mass drug administration (MDA) for trachoma until endemic regions drop below 5% prevalence of active trachoma in children aged 1-9 years. Azithromycin targets the ocular strains of Chlamydia trachomatis that cause trachoma. Regio...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Hamidah Mahmud, Emma Landskroner, Abdou Amza, Solomon Aragie, William W Godwin, Anna de Hostos Barth, Kieran S O'Brien, Thomas M Lietman, Catherine E Oldenburg
Format:	Artigo
Jezik:	Inglês
Izdano:	Public Library of Science (PLoS) 2021-07-01
Serija:	PLoS Neglected Tropical Diseases
Online dostop:	https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0009491&type=printable
Oznake:	Označite Brez oznak, prvi označite!